VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
XRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
XRNChiron Real Estate Inc.
$28.70$380M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXRNFinancials

Chiron Real Estate Inc. (XRN) Income Statement

14Y historyFree accessUpdated daily

Revenue growth has effectively stalled at 0.6% in 2025Q4, while FFO per share experienced a sharp contraction from $6.58 in 2025Q1 to $0.28 in 2025Q4.

Income StatementBalance SheetCash FlowRatios

XRN Income Statement

Annual statement

XRN Income Statement

Chiron Real Estate Inc. (XRN) annual income statement — 14-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Aug'14Aug'13Aug'12
Sales/Revenue156.54M161.03M138.41M140.93M137.17M115.8M93.52M70.73M53.19M30.22M8.08M2.06M380.4K00
Revenue Growth %1.21%16.34%-1.79%2.75%18.45%23.83%32.23%32.96%76%274.07%-441.97%---
Cost of Goods Sold117.92M150.7M29.25M28.08M25.19M15.49M10.87M6.54M3.72M1.86M1.43M1.02M360K00
COGS % of Revenue-93.59%21.13%19.93%18.36%13.37%11.62%9.24%6.99%6.15%17.75%49.46%94.64%--
Gross Profit-1.71M10.32M109.16M112.85M111.98M100.32M82.65M64.19M49.47M28.36M6.65M1.04M20.41K00
Gross Margin %-1.09%6.41%78.87%80.07%81.64%86.63%88.38%90.76%93.01%93.85%82.25%50.54%5.36%--
Gross Profit Growth %--90.54%-3.27%0.78%11.63%21.37%28.76%29.75%74.42%326.8%-5006.57%---
Operating Expenses-15.08M-39.04M76.48M74.99M73.27M63.33M82.65M14.25M27.23M18.61M8.1M1.52M733.95K45.34K50.11K
OpEx % of Revenue--24.25%55.26%53.21%53.42%54.69%88.38%20.15%51.19%61.59%100.29%73.96%192.94%--
Selling, General & Admin23.51M20M21.12M16.85M16.55M16.45M29.96M14.25M9.96M8.61M5.73M865.14K604.87K45.34K50.11K
SG&A % of Revenue-12.42%15.26%11.96%12.06%14.21%32.04%20.15%18.72%28.49%70.87%41.96%159.01%--
Research & Development0000000000-1----
R&D % of Revenue--------0%0%0%----
Other Operating Expenses-2M-59.04M55.36M58.13M56.72M46.88M52.69M017.27M121K130.78K----
Operating Income27.5M49.37M32.68M37.86M38.71M36.99M049.94M22.24M7.35M-2.21M-1.52M-652.21K-45.34K-50.11K
Operating Margin %17.57%30.66%23.61%26.87%28.22%31.94%-70.61%41.82%24.31%-27.41%-73.96%-171.45%--
Operating Income Growth %-51.08%-13.7%-2.19%4.66%--100%124.51%202.72%431.76%--133.79%-1338.54%9.52%-
EBITDA72.35M108.41M88.76M96.87M96.37M84.3M53M75.46M40.2M17.48M161.16K-865.14K-523.13K-45.34K0
EBITDA Margin %46.22%67.32%64.13%68.74%70.26%72.79%56.67%106.69%75.58%57.83%1.99%-41.96%-137.52%--
EBITDA Growth %-28.57%22.14%-8.37%0.52%14.33%59.05%-29.76%87.7%130.01%10745.26%--65.38%-1053.83%--
D&A (Non-Cash Add-back)44.84M59.04M56.08M59.01M57.66M47.31M36.82M25.52M17.96M10.13M2.38M659.67K129.08K050.11K
EBIT92.23M37.69M35.38M52.63M45.23M38.04M16.18M27.06M29.54M7.35M-2.21M-90.14K-353.54K-45.34K-50.11K
Net Interest Income-24.44M-44.57M-28.69M-30.89M-25.23M-19.7M-18.68M-17.47M-14.97M-7.43M-4.14M-1.52M-298.66K00
Interest Income000000000000000
Interest Expense32.75M44.57M28.69M30.89M25.23M19.7M18.68M17.47M14.97M7.43M4.14M----
Other Income/Expense40.29M-56.25M-25.98M-16.13M-18.71M-18.65M-2.5M-40.35M-7.68M-9.96M-6.33M----
Pretax Income58.92M-6.88M6.69M21.73M20M18.34M-2.5M9.59M14.56M-87K-6.35M-1.61M-652.21K-45.34K-50.11K
Pretax Margin %37.64%-4.27%4.83%15.42%14.58%15.84%-2.67%13.56%27.37%-0.29%-78.64%-78.06%-171.45%--
Income Tax000000000-49K4.27M1.52M000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%56.32%-67.21%-94.4%0%0%0%
Net Income53.63M-5.84M6.63M20.61M19.14M17.62M-1.93M9.23M13.49M-38K-6.35M-1.61M-652.21K-45.34K-50.11K
Net Margin %34.26%-3.62%4.79%14.63%13.96%15.22%-2.06%13.06%25.36%-0.13%-78.64%-78.06%-171.45%--
Net Income Growth %2046.88%-187.98%-67.82%7.68%8.63%1015.43%-120.85%-31.55%35600%99.4%--146.74%-1338.54%9.52%-
Net Income (Continuing)58.92M-6.88M6.69M21.73M20M18.34M-2.5M9.59M14.56M-87K-6.35M-1.61M-652.21K-45.34K-50.11K
Discontinued Operations000000000000000
Minority Interest27.6M20.3M21.79M22.23M16.08M14.79M12.96M30.08M30.45M12.68M44.99M0000
EPS (Diluted)4.05-0.910.315.751.024.86-11.252.5215.25-0.05-17.00-161.00-337.25-58.00-62.75
EPS Growth %1217.86%-393.55%-94.61%463.73%-79.01%143.2%-546.43%-83.48%32205.26%99.72%-52.26%-481.47%7.57%-
EPS (Basic)--0.910.315.751.020.97-11.252.5215.25-0.05-17.00-161.00-337.25-58.00-62.75
Diluted Shares Outstanding13.24M13.38M2.64M2.62M2.62M2.43M1.85M1.35M878.84K784.68K372.08K10K1.93K783800
Basic Shares Outstanding13.24M13.38M2.64M2.62M2.62M2.43M1.85M1.35M878.84K784.68K372.08K10K1.93K783800
Dividend Payout Ratio--902.58%286.36%305.19%297.92%-315.91%140.58%------

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

High leverage refinancing risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q4)

FFO Volatility Masks Structural Weakness

As reported in recent financial filings, GMRE's FFO per share experienced a sharp decline to $0.28 in 2025Q4 from $6.58 in 2025Q1, indicating significant earnings instability that warrants close investor scrutiny regarding the sustainability of the company's current dividend payout and overall capital allocation strategy.

The dramatic contraction in FFO per share suggests that the company's reliance on external growth is failing to offset the rising cost of capital. Investors should monitor whether this volatility is a temporary byproduct of portfolio recycling or a permanent impairment of the REIT's ability to generate accretive earnings.

Negative AFFO Signals Cash Burn

Based on the company's reported quarterly data, AFFO has plummeted into deep negative territory, reaching -$101.4M in 2025Q4, which suggests that recurring capital expenditures and leasing costs are significantly outpacing the cash flow generated from the underlying medical office portfolio assets.

This divergence between FFO and AFFO implies that the company is likely capitalizing costs that are effectively recurring in nature, masking the true cash requirements of the business. Such a trend may indicate that the portfolio requires more intensive reinvestment than the triple-net lease structure initially suggests.

NOI Margin Compression Remains Persistent

According to the provided income statement data, the NOI margin experienced a notable collapse to 42.7% in 2025Q3 before recovering to 100% in 2025Q4, a fluctuation that appears inconsistent with a stable triple-net lease model and warrants further investigation into potential property-level expense volatility.

While the NNN structure is designed to insulate the REIT from operating expenses, the erratic margin profile suggests that the company may be absorbing costs that should be tenant-reimbursable. This inconsistency raises questions about the effectiveness of lease enforcement and the quality of the underlying tenant base.

Revenue Growth Stalled by Headwinds

Financial statements reveal that revenue growth has stalled, with a marginal 0.6% increase in 2025Q4 following several quarters of negative growth, suggesting that the company's acquisition-led expansion strategy is currently struggling to gain traction in the prevailing high-interest rate environment.

The lack of meaningful top-line expansion implies that the REIT is unable to source accretive deals that exceed its cost of capital. Without a clear path to organic growth, the company appears increasingly dependent on asset dispositions to manage its balance sheet, which may further limit future revenue potential.

XRN — Frequently Asked Questions

Quick answers to the most common questions about buying XRN stock.

What was Chiron Real Estate Inc.'s (XRN) revenue in 2025?

For fiscal year 2025, Chiron Real Estate Inc. (XRN) reported total revenue of $161.0M.

Is Chiron Real Estate Inc. (XRN) profitable?

Chiron Real Estate Inc. (XRN) reported a net loss of $5.8M for the fiscal year ending 2025.

What is Chiron Real Estate Inc.'s operating profit margin?

Chiron Real Estate Inc. (XRN) reported an operating income of $49.4M, resulting in an operating profit margin of 30.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Chiron Real Estate Inc.'s gross profit and gross margin?

Chiron Real Estate Inc. (XRN) generated $10.3M in gross profit for the year, representing a gross profit margin of 6.4%. This demonstrates the company's core pricing power and production efficiency.